FDA describes 'objectionable conditions' at New York State Psychiatric Institute
APR 18, 20246 MIN
FDA describes 'objectionable conditions' at New York State Psychiatric Institute
APR 18, 20246 MIN
Description
The facility's institutional review board failed to report a 2021 incident and "serious and ongoing noncompliance" by a principal investigator, according to a letter released by the federal agency this week.